KPIs & Operating Metrics(New)
Growth Metrics

AbbVie (ABBV) Total Debt (QoQ) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 5.03%
Dec 31, 2025 -5.41%
Sep 30, 2025 -0.01%
Jun 30, 2025 -4.89%
Mar 31, 2025 1.72%
Dec 31, 2024 -5.54%
Sep 30, 2024 0.63%
Jun 30, 2024 10.70%
Mar 31, 2024 7.45%
Dec 31, 2023 -2.24%
Sep 30, 2023 8.84%
Jun 30, 2023 -10.11%
Mar 31, 2023 -1.86%
Dec 31, 2022 4.74%
Sep 30, 2022 -17.15%
Jun 30, 2022 14.77%
Mar 31, 2022 -17.13%
Dec 31, 2021 -5.00%
Sep 30, 2021 -1.72%
Jun 30, 2021 -3.98%
Mar 31, 2021 -0.58%
Dec 31, 2020 4.48%
Sep 30, 2020 0.26%
Jun 30, 2020 29.76%
Mar 31, 2020 0.50%
Dec 31, 2019 63.99%
Sep 30, 2019 3.92%
Jun 30, 2019 3.91%
Mar 31, 2019 -8.10%
Dec 31, 2018 -2.00%
Sep 30, 2018 17.53%
Jun 30, 2018 7.43%
Mar 31, 2018 -0.26%
Dec 31, 2017 -15.25%
Sep 30, 2017 0.43%
Jun 30, 2017 -0.24%
Mar 31, 2017 0.30%
Dec 31, 2016 -1.32%
Sep 30, 2016 -0.11%
Jun 30, 2016 24.96%
Mar 31, 2016 -4.40%
Dec 31, 2015 -2.66%
Sep 30, 2015 3.20%
Jun 30, 2015 111.66%
Mar 31, 2015 34.12%
Dec 31, 2014 -24.35%
Sep 30, 2014 0.01%
Jun 30, 2014 0.71%
Mar 31, 2014 -2.16%
Dec 31, 2013 2.13%
Sep 30, 2013 -2.29%
Jun 30, 2013 0.77%
Mar 31, 2013 -6.56%